Status and phase
Conditions
Treatments
About
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
108 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Stephanie Hartman, MD; Karen Ahern, BSN MBA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal